ANTIBODIES

Contributor Information
- Name Ayham Alnabulsi
- Institute Vertebrate Antibodies Limited
Tool Details
- Tool name: Anti-Cytochrome P450 4Z1 [N7-P2G5*D8]
- Clone: N7-P2G5*D8
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; IHC ; WB
- Strain: Balb/c
- Description: CYP4Z1 was only detected in breast cancer samples (potentially important clinical marker).
- Immunogen: Ovalbumin-conjugated synthetic peptide KLAPDHSRPP (C-terminal sequence)
- Isotype: IgG1 kappa
- Research area: Cancer; Tissue-specific biology; Cell biology; Cell signaling and signal transduction; Metabolism
- Myeloma used: P3X63Ag8.653
- For Research Use Only
Target Details
- Target: Cytochrome P450, family 4, subfamily Z, polypeptide 1 (CYP4Z1)
- Target background: CYP4Z1 was only detected in breast cancer samples (potentially important clinical marker).
Application Details
- Application: ELISA ; IHC ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15ðC to -25ðC
- Shipping conditions: Shipping at 4ðC
Related Tools
References
- • Alnabulsi et al. 2017. Br J Cancer. :. PMID: 28557975.
- • The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.
- • Alnabulsi et al. 2016. Characterisation of Arachidonic Acid Metabolising Enzymes in Colorectal Cancer. J Pathol. 240 Suppl 1:S1-S48. PMID: 27747872
- • Nottingham Pathology 2016. 9th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 28 June - 1 July 2016.